Significant increase in volume has been observed in Jagsonpal Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE observed a significant increase in trading volume in Jagsonpal Pharmaceuticals Limited. The exchange has written to the company to obtain the latest relevant information that could explain the unusual price/volume movement. The company's response is awaited and will be shared with the market once received. This is a routine market surveillance measure triggered by abnormal trading activity.
This is a cautionary disclosure, not a penalty or adverse action. Short-term volatility may persist until the company responds. Shareholders should wait for the company's clarification before drawing any conclusions about the stock's movement.